Matching geography Reports matching your search in: Join Alert Me now!Receive bi-weekly email alerts on new market research Sign up today!
|
Gene Therapy: market research reports
Gene therapy is a technique used to treat or prevent diseases by the insertion, replacement reparation, regulation or removal of genes within an individual’s cells and biological tissues.
The most common approach to gene therapy is insertion, by which a functional gene is inserted into the genome to replace a disease-causing mutated gene. Another method is modifying the gene sequence by substituting a mutated gene through homologous recombination. Selective reverse mutation is a type of gene therapy in which an abnormal gene is repaired and returned to its normal function. Gene regulation involves the “turning on or turning off” of a particular gene to alter its functionality.
Types of gene therapy include germ line gene therapy and somatic gene therapy. In germ-line gene therapy, germ cells (i.e. sperms or eggs) are modified by the insertion of functional genes. These genetic changes would be heritable and theoretically passed on to future generations. In somatic gene therapy, genes are transferred into somatic cells, effecting only the patient with no risk to passing on the altered genes to offspring.
Gene Therapy market research reports and industry analysis
Gene Therapy in Oncology Drug Pipeline Update 2012
10/16/2012 | published by: BioSeeker Group AB
... years amount to another 95 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 88 different targets. ...
|
more...
|
$2,273.00
|
Translational Regenerative Medicine: Market Prospects 2012-2022
8/31/2012 | published by: Visiongain
... to 2022. There you investigate the most lucrative areas in that research field, industry and market. Discover prospects for tissue-engineered products, stem cell treatments and gene therapy. We pack our study with information and analysis ...
|
more...
|
$2,739.00
|
|
|
$349.99
|
|
|
$199.99
|
Cancer Bundle
8/1/2012 | published by: TriMark Publications
... Testing World Markets. Cancer Therapeutics Markets. Cancer Vaccines Markets. Companion Diagnostics in Personalized Medicine and Cancer Therapy. Cytology and HPV Testing World Markets. Game Changers in Breast Cancer Therapies. Molecular Diagnostics in Cancer Testing. Until ...
|
more...
|
$26,010.00
|
|
|
$3,500.00
|
|
|
$3,500.00
|
Neuroprotective Products: World Market Prospects 2012-2022
5/10/2012 | published by: Visiongain
... projected sales at overall world market, therapeutic submarket and product level to 2022. The protection of nerve tissues is becoming more important. You can assess the potential for drug revenues there, as well as finding ...
|
more...
|
$2,739.00
|
|
|
$500.00
|
Global Gene Therapy Market Analysis
4/1/2012 | published by: RNCOS
... generation, the gene therapy market holds tremendous growth potential. As per a new estimation, carried out in our latest study, the global gene therapy industry will reach US$ 325 Million by the end of 2015 ...
|
more...
|
$1,200.00
|
Gene Therapy in Oncology Drug Pipeline Update 2012
2/21/2012 | published by: BioSeeker Group AB
... years amount to another 94 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 88 different targets. ...
|
more...
|
$2,249.00
|
Gene Therapy
2/1/2012 | published by: Global Industry Analysts
... such as AnGes MG, Inc., BioSante Pharmaceuticals, GenVec, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based ...
|
more...
|
$4,500.00
|
|
|
$2,265.00
|
|
|
$149.99
|
|
|
$299.99
|
Gene Therapy
1/1/2011 | published by: Global Industry Analysts
... such as AnGes MG Inc., BioSante Pharmaceuticals, GenVec, Genzyme Corporation, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. Company profiles are ...
|
more...
|
$4,500.00
|
|
|
$2,500.00
|
|
|
$1,215.00
|
|
|
$4,650.00
|
|
|
$3,500.00
|
Epigenetics
2/1/2010 | published by: Global Industry Analysts
... companies including many key and niche players worldwide such as Celgene Corporation, CellCentric Ltd., CellCentric Ltd., Epigentek Group, Inc., Genpathway, Inc., Merck & Co., Inc., MGI Pharma, Inc., Millipore Corporation, OncoMethylome Sciences S.A., and Orion ...
|
more...
|
$4,500.00
|
U.S. Epigenetics Markets
12/31/2009 | published by: Frost & Sullivan
... and chromatin immunoprecipitation segments. Each segment covers competitive structure, market share analysis, revenue forecasts, and product analysis. The key market drivers and restraints, challenges, strategies, and competitive factors are covered for the total market overview.
|
more...
|
$6,000.00
|
|
|
$3,800.00
|
|
|
$3,835.00
|
Global Stem Cell and Advanced Technologies Market
11/1/2009 | published by: MarketsandMarkets
... embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy ...
|
more...
|
$4,650.00
|
|